![]() |
產(chǎn)地 | 進(jìn)口、國(guó)產(chǎn) |
品牌 | 上海莼試 |
保存條件 | Store at -20 °C |
貨號(hào) | CS10189 |
應(yīng)用范圍 | WB=1:100-500 ELISA=1:500-1000 IP=1:20-100 IHC-P=1:100-500 IHC-F=1:100-500 Flow-Cyt=1:100-500 IF=1:100-500 |
CAS編號(hào) | |
抗體名 | Anti-phospho-PDHA1(Ser293) |
克隆性 | |
靶點(diǎn) | 詳見說明書 |
適應(yīng)物種 | 詳見說明書 |
形態(tài) | 詳見說明書 |
宿主 | 詳見說明書 |
亞型 | IgG |
標(biāo)識(shí)物 | 詳見說明書 |
濃度 | 1mg/1ml% |
免疫原 | KLH conjugated Synthesised phosphopeptide derived from human PDHA1 around the phosphorylation site of Ser293 |
全、新、優(yōu)、品、好四大特點(diǎn):
磷酸化丙酮酸脫氫酶α1抗體費(fèi)用 全:公司提供上萬種產(chǎn)品,涵蓋了生物試劑,elisa試劑盒,標(biāo)準(zhǔn)品,培養(yǎng)基,原裝耗材,抗體、培養(yǎng)基、ATCC細(xì)胞等,基本上各種科研所需產(chǎn)品在我司都能找到。
新:產(chǎn)品更新速度較快,基本上每周都有新產(chǎn)品出現(xiàn)。
優(yōu):產(chǎn)品質(zhì)量好,投訴比較少。
好:我公司具有優(yōu)質(zhì)的技術(shù)團(tuán)隊(duì),產(chǎn)品一旦售出,實(shí)驗(yàn)過程中遇到困難可提供在線技術(shù)咨詢。使您使用產(chǎn)品時(shí)沒有任何的后顧之憂。
磷酸化丙酮酸脫氫酶α1抗體費(fèi)用 英文名稱 Anti-phospho-PDHA1(Ser293)
中文名稱 磷酸化丙酮酸脫氫酶α1抗體費(fèi)用
別 名 mitochondrial; somatic form; ODPA_HUMAN; PDH; PDHA1; PDHCE1A; PDHE1 A type I; PDHE1-A type I; PHE1A; Pyruvate Dehydrogenase (lipoamide) alpha 1; Pyruvate Dehydrogenase E1 alpha; Pyruvate dehydrogenase E1 component subunit alpha; Pyruvate dehydrogenase E1 component subunit alpha, somatic form, mitochondrial.
產(chǎn)品屬性:
濃 度 1mg/1ml
規(guī) 格 0.1ml/100μg
抗體來源 Rabbit
克隆類型 polyclonal
交叉反應(yīng) Human, Mouse, Rat, Chicken, Dog, Pig, Cow, Horse, Rabbit
產(chǎn)品類型 一抗 磷酸化抗體
研究領(lǐng)域 細(xì)胞生物 免疫學(xué) 轉(zhuǎn)錄調(diào)節(jié)因子 激酶和磷酸酶 線粒體
蛋白分子量 predicted molecular weight: 40kDa
性 狀 Lyophilized or Liquid
免 疫 原 KLH conjugated Synthesised phosphopeptide derived from human PDHA1 around the phosphorylation site of Ser293
亞 型 IgG
純化方法 affinity purified by Protein A
儲(chǔ) 存 液 0.01M PBS, pH 7.4 with 10 mg/ml BSA and 0.1% Sodium azide
磷酸化丙酮酸脫氫酶α1抗體費(fèi)用 產(chǎn)品應(yīng)用 WB=1:100-500 ELISA=1:500-1000 IP=1:20-100 IHC-P=1:100-500 IHC-F=1:100-500 Flow-Cyt=1:100-500 IF=1:100-500
(石蠟切片需做抗原修復(fù))
not yet tested in other applications.
optimal dilutions/concentrations should be determined by the end user.
保存條件 Store at -20 °C for one year. Avoid repeated freeze/thaw cycles. The lyophilized antibody is stable at room temperature for at least one month and for greater than a year when kept at -20°C. When reconstituted in sterile pH 7.4 0.01M PBS or diluent of antibody the antibody is stable for at least two weeks at 2-4 °C.
Important Note This product as supplied is intended for research use only, not for use in human, therapeutic or diagnostic applications.
產(chǎn)品介紹 The pyruvate dehydrogenase (PDH) complex is a nuclear-encoded mitochondrial multienzyme complex that catalyzes the overall conversion of pyruvate to acetyl-CoA and CO(2), and provides the primary link between glycolysis and the tricarboxylic acid (TCA) cycle. The PDH complex is composed of multiple copies of three enzymatic components: pyruvate dehydrogenase (E1), dihydrolipoamide acetyltransferase (E2) and lipoamide dehydrogenase(E3). The E1 enzyme is a heterotetramer of two alpha and two beta subunits. This gene encodes the E1 alpha 1 subunit containing the E1 active site, and plays a key role in the function of the PDH complex. Mutations in this gene are associated with pyruvate dehydrogenase E1-alpha deficiency and X-linked Leigh syndrome. Alternatively spliced transcript variants encoding different isoforms have been found for this gene.
Function : The pyruvate dehydrogenase complex catalyzes the overall conversion of pyruvate to acetyl-CoA and CO(2), and thereby links the glycolytic pathway to the tricarboxylic cycle.
Subunit : Tetramer of 2 alpha and 2 beta subunits.
Subcellular Location : Mitochondrion matrix.
Post-translational modifications : Phosphorylation at Ser-232, Ser-293 and Ser-300 by PDK family kinases inactivates the enzyme; for this phosphorylation at a single site is sufficient. Dephosphorylation at all three sites, i.e. at Ser-232, Ser-293 and Ser-300, is required for reactivation.
DISEASE : Pyruvate dehydrogenase E1-alpha deficiency (PDHAD) [MIM:312170]: An enzymatic defect causing primary lactic acidosis in children. It is associated with a broad clinical spectrum ranging from fatal lactic acidosis in the newborn to chronic neurologic dysfunction with structural abnormalities in the central nervous system without systemic acidosis. Note=The disease is caused by mutations affecting the gene represented in this entry.
X-linked Leigh syndrome (X-LS) [MIM:308930]: Early-onset progressive neurodegenerative disorder with a characteristic neuropathology consisting of focal, bilateral lesions in one or more areas of the central nervous system, including the brainstem, thalamus, basal ganglia, cerebellum, and spinal cord. The lesions are areas of demyelination, gliosis, necrosis, spongiosis, or capillary proliferation. Clinical symptoms depend on which areas of the central nervous system are involved. The most common underlying cause is a defect in oxidative phosphorylation. LS may be a feature of a deficiency of any of the mitochondrial respiratory chain complexes. Note=The disease is caused by mutations affecting the gene represented in this entry.
Database links : UniProtKB/Swiss-Prot: P08559.3
實(shí)驗(yàn)流程:
正在熱銷的相關(guān)產(chǎn)品:
Human Endostatin 人內(nèi)皮抑素Multi-class antibodies規(guī)格: 48T
Anti-CK7 抗細(xì)胞角蛋白7抗體Multi-class antibodies規(guī)格: 0.2ml
Rhesus antibody Rh NRF-1 核呼吸因子-1抗體 規(guī)格 0.1ml
Unstained Protein Molecular Weight Marker 低范圍非預(yù)染蛋白質(zhì)分子量標(biāo)準(zhǔn)(14.4-116kDa)/7條帶 500ul(100次)
TDRD9 英文名稱: 缺氧誘導(dǎo)蛋白HIG1抗體 0.2ml
C8orf48 英文名稱: 8號(hào)染色體開放閱讀框48抗體 0.2ml
Anti-CK7 抗細(xì)胞角蛋白7抗體Multi-class antibodies規(guī)格: 0.2ml
Tsg101(Tumor susceptibility gene 101 protein) Tsg101抗原Multi-class antibodies規(guī)格: 0.5mg
Anti-CTNNAL1 粘附分子相關(guān)蛋白a1抗體Multi-class antibodies規(guī)格: 0.1ml
Rhesus antibody Rh PDCD4 凋亡相關(guān)蛋白4抗體 規(guī)格 0.2ml
CSF1R Kit Human 人 CSF1R / MCSF Receptor / CD115 ELISA配對(duì)抗體 ELISA
TSARG2 英文名稱: 形成相關(guān)凋亡蛋白2抗體 0.2ml
Casein 英文名稱: 酪蛋白抗體 0.1ml
Anti-CTNNAL1 粘附分子相關(guān)蛋白a1抗體Multi-class antibodies規(guī)格: 0.1ml
NOS-2 peptide 合成酶-2多肽抗原Multi-class antibodies規(guī)格: 0.5mg
Anti-AQP2 水通道蛋白-2抗體Multi-class antibodies規(guī)格: 0.1ml
Rhesus antibody Rh phospho-ATG7(Ser95) 磷酸化自噬相關(guān)蛋白7抗體 規(guī)格 0.1ml
山羊抗人 IgM/HRP 0.1ml 美國(guó)Jackson公司分裝
Viperin 英文名稱: 病毒抑制蛋白Viperin抗體 0.2ml
Dio3 英文名稱: 甲狀腺素5'脫酶3抗體 0.1ml
Anti-AQP2 水通道蛋白-2抗體Multi-class antibodies規(guī)格: 0.1ml
人絨毛膜間充質(zhì)基質(zhì)細(xì)胞
C6/36 白紋伊蚊細(xì)胞
PRSS27 Others Human 人 PRSS27 / Pancreasin / Marapsin 人細(xì)胞裂解液 (陽(yáng)性對(duì)照)
CL-0102Hep 3B(人細(xì)胞)5×106cells/瓶×2
人真皮微內(nèi)皮細(xì)胞裂解物HDMECL
人膀胱上皮永生化細(xì)胞;SV-HUC-1 人主動(dòng)脈平滑肌細(xì)胞完全培養(yǎng)基 100mL
CL-0108HIC(人小細(xì)胞)5×106cells/瓶×2
CD276 Others Rat 大鼠 B7-H3 / CD276 人細(xì)胞裂解液 (陽(yáng)性對(duì)照)
人表皮黑色素細(xì)胞-深色素裂解物HELM-d L
Anglne細(xì)胞,人細(xì)胞系 大黃魚EPC細(xì)胞,EPC細(xì)胞 上皮細(xì)胞Many types of cells包裝:5 × 105次方(1ml)
Calu-6(人肺退行性癌細(xì)胞) 5×106cells/瓶×2
HPrSMC Pellet 人類平滑肌細(xì)胞團(tuán)塊 > 1 mio.cells 人星形膠質(zhì)細(xì)胞cDNAHA cDNA
磷酸化丙酮酸脫氫酶α1抗體費(fèi)用 人絨毛膜間充質(zhì)基質(zhì)細(xì)胞
C6/36 白紋伊蚊細(xì)胞
PRSS27 Others Human 人 PRSS27 / Pancreasin / Marapsin 人細(xì)胞裂解液 (陽(yáng)性對(duì)照)
CL-0102Hep 3B(人細(xì)胞)5×106cells/瓶×2
人真皮微內(nèi)皮細(xì)胞裂解物HDMECL
人膀胱上皮永生化細(xì)胞;SV-HUC-1 人主動(dòng)脈平滑肌細(xì)胞完全培養(yǎng)基 100mL
技術(shù)外包服務(wù):
★磷酸化丙酮酸脫氫酶α1抗體費(fèi)用 分子生物學(xué):質(zhì)粒抽提、PCR、Q-PCR、RT-PCR、分子生物學(xué):基因合成、引物合成、基因測(cè)序、載體構(gòu)建等
★蛋白工程:原核、哺乳動(dòng)物蛋白表達(dá)系統(tǒng)等
★病毒包裝:腺病毒、慢病毒等
★抗體工程:磁珠分選、病理染色、WB、ELISA、IP、IF、IHC、FACS、Confocal等等
★細(xì)胞工程:細(xì)胞表型分析(凋亡、增殖、周期、遷移、侵襲、修復(fù)、克隆形成)、細(xì)胞培養(yǎng)、細(xì)胞膜制備、穩(wěn)定細(xì)胞株構(gòu)建、細(xì)胞RNAi技術(shù)等等。